CR9231A - Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion - Google Patents

Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion

Info

Publication number
CR9231A
CR9231A CR9231A CR9231A CR9231A CR 9231 A CR9231 A CR 9231A CR 9231 A CR9231 A CR 9231A CR 9231 A CR9231 A CR 9231A CR 9231 A CR9231 A CR 9231A
Authority
CR
Costa Rica
Prior art keywords
compositions
manufacturing
pirroles
replaced
contain
Prior art date
Application number
CR9231A
Other languages
English (en)
Inventor
Baptiste Ronan
Michael Tabart
Catherine Souaille
Fabrice Viviani
Eric Bacque
Jean Philippe Lettalec
Pascal Desmazeau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9231(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CR9231A publication Critical patent/CR9231A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pirroles sustituidos, composiciones que los contienen, proceso de fabricacion y utilizacion. La presente invencion se refiere particularmente a la preparacion de pirroles sustituidos, a las composiciones que los contienen, a su proceso de preparacion, y a su utilizacion como medicamento, en particular como agentes anticancerigenos.
CR9231A 2005-02-10 2007-07-06 Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion CR9231A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
CR9231A true CR9231A (es) 2007-10-23

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9231A CR9231A (es) 2005-02-10 2007-07-06 Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion

Country Status (36)

Country Link
US (1) US7592365B2 (es)
EP (1) EP1851198B1 (es)
JP (1) JP2008530061A (es)
KR (1) KR20070101317A (es)
CN (1) CN101115716A (es)
AR (1) AR052571A1 (es)
AT (1) ATE419234T1 (es)
AU (1) AU2006212106A1 (es)
BR (1) BRPI0606955A2 (es)
CA (1) CA2596822A1 (es)
CR (1) CR9231A (es)
CY (1) CY1108916T1 (es)
DE (1) DE602006004566D1 (es)
DK (1) DK1851198T3 (es)
DO (1) DOP2006000028A (es)
EA (1) EA013060B1 (es)
ES (1) ES2319926T3 (es)
FR (1) FR2881742B1 (es)
GT (1) GT200600048A (es)
HR (1) HRP20090158T1 (es)
IL (1) IL184488A0 (es)
MA (1) MA29248B1 (es)
MX (1) MX2007008789A (es)
MY (1) MY142082A (es)
NO (1) NO20074528L (es)
PA (1) PA8661601A1 (es)
PE (1) PE20061086A1 (es)
PL (1) PL1851198T3 (es)
PT (1) PT1851198E (es)
RS (1) RS50806B (es)
SI (1) SI1851198T1 (es)
TN (1) TNSN07241A1 (es)
TW (1) TW200640858A (es)
UY (1) UY29371A1 (es)
WO (1) WO2006084996A1 (es)
ZA (1) ZA200706157B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
NZ576291A (en) * 2006-10-23 2011-10-28 Lexicon Pharmaceuticals Inc Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
EP1436279B8 (en) * 2001-09-21 2008-10-29 Smithkline Beecham Corporation Chemical compounds
US7307097B2 (en) 2001-09-27 2007-12-11 Smithkline Beechman Corporation Chemical compounds
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
AU2004221881A1 (en) * 2003-03-13 2004-09-30 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
GT200600048A (es) 2006-07-03
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
AU2006212106A1 (en) 2006-08-17
RS50806B (sr) 2010-08-31
US7592365B2 (en) 2009-09-22
NO20074528L (no) 2007-10-31
SI1851198T1 (sl) 2009-06-30
PE20061086A1 (es) 2006-11-30
PT1851198E (pt) 2009-03-26
DE602006004566D1 (de) 2009-02-12
ES2319926T3 (es) 2009-05-14
EP1851198A1 (fr) 2007-11-07
AR052571A1 (es) 2007-03-21
MY142082A (en) 2010-08-30
JP2008530061A (ja) 2008-08-07
PA8661601A1 (es) 2006-09-08
BRPI0606955A2 (pt) 2009-07-28
US20080167368A1 (en) 2008-07-10
FR2881742B1 (fr) 2007-09-07
WO2006084996A1 (fr) 2006-08-17
UY29371A1 (es) 2006-10-02
ATE419234T1 (de) 2009-01-15
MX2007008789A (es) 2007-09-11
IL184488A0 (en) 2007-10-31
DK1851198T3 (da) 2009-05-04
CN101115716A (zh) 2008-01-30
EP1851198B1 (fr) 2008-12-31
DOP2006000028A (es) 2006-09-15
CY1108916T1 (el) 2014-07-02
EA013060B1 (ru) 2010-02-26
ZA200706157B (en) 2008-11-26
TNSN07241A1 (en) 2008-11-21
FR2881742A1 (fr) 2006-08-11
TW200640858A (en) 2006-12-01
HRP20090158T1 (en) 2009-05-31
CA2596822A1 (fr) 2006-08-17
EA200701688A1 (ru) 2007-12-28
PL1851198T3 (pl) 2009-06-30

Similar Documents

Publication Publication Date Title
UY29341A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
CR9463A (es) Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
UY29248A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
UY29361A1 (es) Pirroles e imidazoles sustituídos, composiciones que los contienen, procedimiento de fabricación y utilización
UY30276A1 (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapéutica
DOP2006000015A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
CR10749A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
CR9115A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR10382A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
DOP2005000246A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR10428A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion
UY29235A1 (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparación, composiciones que las contienen y utilización
UY29501A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)